FDA Issues Update on Propofol Shortage

Chicago — (February 26, 2010) 


On February 24, 2010, the Food and Drug Administration (FDA) posted updated information regarding the availability of propofol on its website.

In summary, APP, one of the manufacturers of propofol, is launching an FDA approved generic version of propofol (10 mg/ml injection) that should help alleviate the shortages. With the availability of this new product, importation and distribution of Propoven 1% (propofol 1%) from APP will be suspended. Meanwhile, the other two other manufacturers, Teva and Hospira, are back online and are working to restore availability to meet market demand.

For complete details of this announcement, please visit the FDA’s website

ASA will continue to work closely with the FDA to ensure that necessary anesthesia drugs remain readily available. If you or your facility are experiencing difficulty obtaining any drug, please contact the FDA’s drug shortage group at drugshortages@fda.hhs.gov.


Founded in 1905, the American Society of Anesthesiologists (ASA) is an educational, research and scientific society with more than 52,000 members organized to raise and maintain the standards of the medical practice of anesthesiology. ASA is committed to ensuring physician anesthesiologists evaluate and supervise the medical care of patients before, during and after surgery to provide the highest quality and safest care every patient deserves.

For more information on the field of anesthesiology, visit the American Society of Anesthesiologists online at asahq.org. To learn more about the role physician anesthesiologists play in ensuring patient safety, visit asahq.org/WhenSecondsCount. Join the ANESTHESIOLOGYTM 2014 social conversation today. Like ASA on Facebook, follow ASALifeline on Twitter and use the hashtag #ANES2014.



American Society of Anesthesiologists